Article (clinical trial correlative study)31 December 2025 (online)
Home/Academy/Journal Finder/Cancer Cell
Oncology
Cancer Cell
Cell Press (Elsevier)
Cancer research across molecular and cellular biology, the tumour microenvironment and clinical oncology, including translational studies that link basic discovery with clinical practice.
ISSN 1535-6108 (print)ISSN 1878-3686 (online)Access Hybrid
HybridPublishing model
Verified 2026-11Field-level — see each tab
CiteScoreNot yet verified
Impact FactorNot yet verified
QuartileNot yet verified
Article Fee (APC)Not published
First DecisionNot yet verified
Acceptance RateNot yet verified
Overview
Cancer Cell is published by Cell Press (Elsevier). Cancer research across molecular and cellular biology, the tumour microenvironment and clinical oncology, including translational studies that link basic discovery with clinical practice.
Key information
PublisherCell Press (Elsevier)
ISSN (Print)1535-6108
ISSN (Online)1878-3686
Publishing modelHybrid
Journal websiteNot yet verified
CountryNot yet verified
FrequencyNot yet verified
Subject categoryOncology
EditorNot yet verified
Established2002
SubmissionsNot yet verified
Launch year per the journal's Wikipedia entry (first issue 1 February 2002). Word limits found only in third-party guides and are not used.
Aims & scope
- Cancer research across molecular and cellular biology, the tumour microenvironment and clinical oncology, including translational studies that link basic discovery with clinical practice.
No per-article-type breakdown verified yet for this journal.
General formatting rules that apply across article types. Specific word, abstract, reference and figure limits vary by article type — see the Article types tab for those.
General requirements
Title & running titleundefined
Reference styleundefined
Figures & tablesundefined
Word limitsundefined
Manuscript template
Not yet verified
Information on the submission process and the ethics and publication standards Cancer Cell applies.
Submission process
Submission systemNot yet verified
Author guidelinesNot yet verified
Account requiredNot yet verified
Ethics & publication standards
Not yet verified
Data availability
Not yet verified
Document and declaration checklists (cover letter, disclosures, registration numbers, etc.) follow ICMJE recommendations generally — we have not independently itemized Cancer Cell's exact required-documents list, so check the live author guidelines before submitting.
Sample articles
Recent, relevant articles published in Cancer Cell. These examples help you understand the journal's scope, style and expected quality — we only list one once its title, DOI, year and article type are verified against the publisher's own page.
Review31 December 2025 (online)
Review31 December 2025 (online)
Filter examples
Article type
Learn from examples
- Review the structure, formatting and presentation style the journal actually publishes.
- Use examples together with the Article types and Manuscript specs tabs, not as a substitute for the journal's own guidelines.
- Check article-type-specific requirements before drafting.
Title, authors, date, article type and DOI confirmed via PubMed records (Nov 2026); dates are online-publication dates as listed in PubMed.
General stages a manuscript moves through at most peer-reviewed journals — this sequence is standard academic-publishing practice, not a claim we've verified against Cancer Cell's own workflow. Durations below are shown only where the publisher has actually disclosed them.
Submission
Manuscript submitted via the journal's submission system.
Initial screening
Administrative and scope check by the editorial office.
Editorial decision
Editor decides whether to send the manuscript for peer review.
Peer review
External review by expert referees.
First decision
Accept, minor/major revision, or reject.
Revisions
Author submits a revised manuscript, if requested.
Final decision
Editor confirms acceptance.
Publication
Online-first, then the print/issue assignment if applicable.
Key timeline statistics
First decision timeNot yet verified
Acceptance to publicationNot yet verified
Total time to publicationNot yet verified
Factors that may affect timeline
- Type and complexity of the study
- Speed of author response to reviewer comments
- Number of revision rounds
- Availability of expert reviewers
- Editorial and production workload
- Compliance with the journal's own guidelines
General tips for faster processing
- Confirm the manuscript fits the journal's scope before submitting
- Follow the author guidelines and formatting requirements closely
- Respond to reviewer comments completely and promptly
- Submit all required documents and declarations at the time of submission
The stage sequence and general tips above reflect typical academic-publishing practice, not data we've verified against Cancer Cell specifically. Any duration we haven't independently confirmed from the publisher reads as "not yet verified" rather than an estimate.
Indexing and abstracting services
MEDLINE (PubMed)
Scopusnot yet verified
Web of Sciencenot yet verified
Embasenot yet verified
DOAJnot yet verified
Google Scholarnot yet verified
EBSCOhostnot yet verified
ProQuestnot yet verified
OCLC WorldCatnot yet verified
MEDLINE: recent PubMed records for this journal carry MeSH indexing (checked via PubMed, Nov 2026). Scopus and Web of Science coverage not independently confirmed here.
Citation metrics
Not yet verified
Requires a licensed Scopus/JCR/SCImago lookup we have not run for this title.
Not yet verified
Requires a licensed Scopus/JCR/SCImago lookup we have not run for this title.
Not yet verified
Requires a licensed Scopus/JCR/SCImago lookup we have not run for this title.
Not yet verified
Requires a licensed Scopus/JCR/SCImago lookup we have not run for this title.
Journal quartile
CategoryQuartilePercentile
OncologyNot yet verifiedNot yet verified
Scopus and Web of Science classify journals into their own category sets — we show the one subject category we've confirmed rather than listing categories we haven't checked.
Additional metrics
h-indexNot yet verified
Total citationsNot yet verified
Documents publishedNot yet verified
Citations per documentNot yet verified
CiteScore details (2024)
Citations 2021–2024Not yet verified
Documents 2021–2024Not yet verified
CiteScore 2024Not yet verified
Metric notes
- CiteScore here is an aggregate pulled from a third-party metrics site, not fetched from Scopus directly — confirm there before citing it.
- Impact Factor, SJR, SNIP, quartile, h-index and citation counts require a licensed Scopus/JCR/SCImago lookup we have not independently run for this title.
- Indexing status reflects only what we've checked against the publisher or the NLM Catalog — an item marked not-yet-verified may still index this journal.
Indexing and metric information is shown only where we've verified it directly, and may change — confirm current figures with the indexing services themselves.Search on Scopus Search on Journal Citation Reports
Publication charges and author-facing fees. Cell Press (Elsevier) has not published a per-route APC schedule we could independently verify for Cancer Cell — every amount below is honestly unknown rather than estimated, not a $0 fee.
Publication charges (APC)
Publishing routeAmountNotes
Open access (Gold OA)Not disclosed by publisherPublication and immediate open access
Hybrid (optional OA)Not disclosed by publisherOptional open access for accepted articles
Subscription (no OA)Not disclosed by publisherAccess via institutional subscription
Additional charges
ItemAmountNotes
Colour figuresNot disclosed by publisherCheck the journal's current policy
Page chargesNot disclosed by publisherNot confirmed either way for this title
Supplementary materialNot disclosed by publisherNot confirmed either way for this title
Licence & copyright
- Publishing agreements and licence terms are set by the publisher and vary by publishing route.
- We have not independently verified Cancer Cell's specific licence (e.g. a named Creative Commons variant) — confirm on the journal website before relying on it.
Based on what Cell Press (Elsevier) has publicly stated for Cancer Cell as of our last check — verify current fees and policy on the journal website before budgeting or submitting.
- Best fit for manuscripts in cancer research across molecular and cellular biology, the tumour microenvironment and clinical oncology, including translational studies that link basic discovery with clinical practice. — not a narrow subspecialty-only readership.
These notes are Pubrica's own read of the journal's published guidelines, not a claim about editorial preference or acceptance likelihood.
Verified against ISSN metadata, Elsevier pages and PubMed records.